Your birth certificate says 45 but your heart may be 55: Study shows how Americans' hearts are ageing faster than them
What is 'risk age' and why it matters
The study, based on data from over 14,000 adults, introduces a new concept called 'risk age', a way of communicating heart disease risk not through percentages, but by comparing a person's heart to that of someone in perfect cardiovascular health.
Study reveals that many Americans have hearts that function years older than their actual age. (Pixabay)
Researchers found striking disparities based on socioeconomic status. Adults with only a high school education or less showed significantly older heart ages, up to 10 years older in some cases. Income mattered even more: lower-income men had hearts ageing more than 8 years ahead of their age, and nearly 1 in 3 had heart ages 10+ years older.
Impact of education, income and race on heart ageing
Non-Hispanic Black adults had the highest gaps, especially men, whose hearts aged an average of 8.5 years beyond their chronological age. Hispanic and Asian adults also showed disparities, but Asian women had the smallest gap, less than three years.
Instead of saying a patient has a 15 percent risk of heart disease, doctors can now say their heart functions like someone a decade older. This 'risk age' method may help younger adults understand their health risks more clearly and encourage better prevention efforts.
While individual choices matter, the research highlights how education and income levels shape heart health deeply. The findings call for not just lifestyle changes, but systemic solutions to close the cardiovascular health gap in America.
Note to readers: This article is for informational purposes only and not a substitute for professional medical advice. Always seek the advice of your doctor with any questions about a medical condition.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economic Times
23 minutes ago
- Economic Times
Trump says he's cut drug prices by up to 1,500%. That's not possible
Synopsis Donald Trump claimed significant drug price cuts, even up to 1500%. Experts refute this, stating such cuts are impossible. They suggest it would mean people are paid to take medicine. The White House defended Trump, citing price differences with other nations. Trump also mentioned future price drops. Some drugmakers are open to cuts. AP Days after he sent letters instructing top pharmaceutical manufacturers to use a "most favored nation" pricing model for prescription drugs, President Donald Trump told reporters on Sunday that he had cut costs by up to 1,500%. But Trump's grandiose claim is mathematically impossible. Here's a closer look at the facts. TRUMP: "You know, we've cut drug prices by 1,200, 1,300, 1,400, 1,500%. I don't mean 50%, I mean 14 - 1,500%." THE FACTS: This is false. Cutting drug prices by more than 100% would theoretically mean that people are being paid to take medications. The Trump administration has taken steps to lower prescription drug prices, but experts say there's no indication costs have seen such a massive drop. Geoffrey Joyce, director of health policy at the University of Southern California's Schaeffer Center, called Trump's claim "total fiction" made up by the Republican president. He agreed that it would amount to drug companies paying customers, rather than the other way around. "I find it really difficult to translate those numbers into some actual estimates that patients would see at the pharmacy counter," said Mariana Socal, an associate professor of health policy and management at Johns Hopkins University who studies the U.S. pharmaceutical market. She added that Trump's math is "really hard to follow." Asked what Trump was using to back up his claim, White House spokesman Kush Desai said: "It's an objective fact that Americans are paying exponentially more for the same exact drugs as people in other developed countries pay, and it's an objective fact that no other Administration has done more to rectify this unfair burden for the American people." The White House provided a chart of price differentials for drugs in the U.S. and comparable countries, but did not offer any other evidence. On Sunday, Trump also described cuts to drug prices as a future development, not that already happened. "So we'll be dropping drug prices," he said. "It will start over the next two to three months by 1,200, 1,300 and even 1,400%." Prices for most prescription drugs - unbranded generics are the exception - are higher in the U.S. than they are in other high-income countries. This is in large part due to the way drug prices are negotiated in the United States. Trump made his recent appeal in letters to 17 pharmaceutical manufacturers, the White House announced last week. He asked them to reduce costs in the U.S. by matching the lowest prices of prescriptions drugs in other comparably developed countries. Some drugmakers have since indicated that they are open to cutting costs. This move follows an executive order Trump signed in May setting a 30-day deadline for drugmakers to electively lower prices in the U.S. or face new limits in the future over what the government will pay. The federal government has the most power to shape the price it pays for drugs covered by Medicare and Medicaid. It's unclear what - if any - impact the Trump administration's efforts will have on millions of Americans who have private health insurance. Socal pointed out that if drug manufacturers had cut costs to the extent Trump claims, they would be shouting it from the rooftops, especially given the heat they've taken over the years for their pricing practices. "My expectation would be that they would make announcements - public announcements - and that those announcements would come way in advance of the actual effective dates when those price cuts would come into effect," she said. Joyce agreed that there has been no indication of a substantial cut. "Not at all, not at all, none whatsoever," he said. "And let alone 1,500."
Time of India
3 hours ago
- Time of India
Milk testing flags LSD early; 355 cases reported in 11 dists of state
SLUG: FRESH WAVE Ahmedabad: Gujarat is facing a fresh wave of lumpy skin disease (LSD), with 355 confirmed cases and eight animal deaths reported as of Monday, sparking renewed concern among farmers and veterinary officials. This is the second major outbreak in three years, with the 2022 episode having claimed around 1,500 livestock, mostly in the north Gujarat region. Officials from the state animal husbandry department said that early detection of the virus was made possible through proactive ground-level surveillance, especially by testing milk samples for viral and bacterial presence at the source. This form of milk-based disease surveillance served as a critical early warning signal, according to sources in the department. You Can Also Check: Ahmedabad AQI | Weather in Ahmedabad | Bank Holidays in Ahmedabad | Public Holidays in Ahmedabad The sources added that initial cases were detected during milk testing in a few districts of the Saurashtra region. Currently, 28 cases were active, mainly in Tapi, Surendranagar, Botad, and Ahmedabad districts. Of the total 355 cases recorded across 104 villages in 11 districts, officials reported that 90% of the infected animals have recovered, 8% are under treatment, and 2% have succumbed. The eight reported deaths include five in Surendranagar, two in Surat, and one in Navsari. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like American Investor Warren Buffett Recommends: 5 Books For Turning Your Life Around Blinkist: Warren Buffett's Reading List Undo Dr Falguni Thakar, director of the state's animal husbandry department, told TOI that while the situation is less severe than in 2022, it remains serious. "The current strain shows low virulence and infectivity. Most fatalities have occurred among sub-adult animals that missed vaccination due to age criteria," she said. More than 6.29 lakh cattle were vaccinated across the state, with vaccinated animals showing minimal infection, Thakar added. Officials have urged farmers and cattle rearers to ensure timely vaccination of all livestock to avoid further spread or loss. The outbreak also puts the spotlight on the state's broader One Health initiative—an integrated approach that monitors human, animal, and environmental health. As part of this, Gujarat has implemented wastewater and air surveillance for the early detection of pathogens, while milk sampling is helping flag potential disease outbreaks in livestock. In Ahmedabad, wastewater monitoring is already in use to track early signs of Covid-19. Similar methods applied to milk are proving instrumental in detecting diseases like LSD. Govt sources confirmed that genetic analysis was underway to determine whether the current virus strain matches the one that wreaked havoc in 2022. With growing concerns over recurring livestock diseases and their economic impact, officials stress that ongoing surveillance, vaccination, and rapid response are crucial to preventing another large-scale crisis. (GFX sent to designers) Table: Most affected Districts in state District Total Cases Active Cases Deaths Surendranagar 137 6 5 Surat 66 2 2 Rajkot 61 2 0 Tapi 28 8 0 Morbi 27 0 0 Amreli 14 2 0 Gujarat 355 28 8 Source: Gujarat Animal Husbandry Department (figures till Aug 4) Pointers: What is Lumpy Skin Disease - LSD is a viral disease primarily seen in cattle and buffalo - Primary symptoms are fever, skin nodules, and enlarged lymph nodes - It is transmitted through bites of insects like flies, mosquitoes, and ticks - It reduces milk production, causes hide damage, and can even lead to death - It is not zoonotic. It is not transmitted to humans
Time of India
6 hours ago
- Time of India
Woman fled America because of allergies: This is how foreign diets affected her body
Image credits: Getty Images O ut of all the imaginable reasons one would be forced to leave America, a woman revealed that her allergies were hers. However, her body saw shocking changes once she moved abroad. For three years, Bee, who uses the diminutive moniker online, had suffered numerous instances of anaphylaxis, hives and stomach aches triggered by the kind of food Americans love, such as cheese, wheat breads and even fresh produce. 'I didn't want to leave behind my entire life in the US, but I didn't feel like I had a choice,' she said of moving to Europe in November 2024, per Newsweek. 'I had to, I felt like my body was slowly shutting down from lack of nutrition because my diet was so limited.' Her diet consists of three foods: broccoli, coconut and chicken. 'Welcome to my series where I test foods that normally give me … histamine reactions in America outside of America to see if I get the same reaction,' she told viewers of her TikTok page, where she documents the changes in her diet and body. She added how she was bracing for the worst after consuming one of her trigger foods in another country, but surprisingly, the reaction never came. Thus, she began a quest of trying every food that used to make her sick and allergic in the US, such as pizza, French fries and pasta. The woman revealed that she was suffering from mast cell activation syndrome (MCAS), an allergy-adjacent condition that can develop out of the blue. MCAS is a condition in which toxins or pathogens cause the immune cells to over-produce chemicals to combat the invader, leading to symptoms such as itching, flushing, hives, abdominal pain, diarrhea, low blood pressure, dizziness and brain fog. Bee's MCAS were triggered from food-based mycotoxins, which she confirmed with a battery of medical tests. In a recent video, she tried eating breaded shrimp at a Thai restaurant. The video received nearly 2.1 million views on TikTok, including that of TikTok's famous allergist, Dr. Rubin. In a post with Bee, he warned people against trying new food without medical supervision. 'You should not be going to another country to try foods if you were prescribed epinephrine because food allergies can be potentially life-threatening.'
